Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9473	Companies
185416	Keywords
117771	Articles
99291	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 05/14/2025 at 18:45, 6 months 21 days ago

Heidelberg Pharma to Unveil Clinical Data on HDP-101 at EHA 2025

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma EHA 2025
PRESS RELEASE

published on 05/14/2025 at 18:40, 6 months 21 days ago

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
Heidelberg Pharma to present new clinical data on lead ATAC candidate HDP-101 at EHA 2025. Promising results in Multiple Myeloma treatment. R&D webinar to follow

Clinical Data Heidelberg Pharma Multiple Myeloma ATAC Candidate EHA 2025
BRIEF

published on 04/24/2025 at 07:21, 7 months 11 days ago

Heidelberg Pharma AG's First Quarter Financial Report for 2025

Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs
PRESS RELEASE

published on 04/24/2025 at 07:16, 7 months 11 days ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx

HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF

published on 03/26/2025 at 09:28, 8 months 10 days ago

Heidelberg Pharma to Showcase ADC Innovations at AACR 2025

Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
PRESS RELEASE

published on 03/26/2025 at 09:23, 8 months 10 days ago

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms

Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC
BRIEF

published on 03/21/2025 at 07:12, 8 months 15 days ago

Heidelberg Pharma Reports 2024 Financial Results and Clinical Progress

Clinical Trials Heidelberg Pharma ADC Technology Multiple Myeloma 2024 Financial Results
PRESS RELEASE

published on 03/21/2025 at 07:07, 8 months 15 days ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted

Financial Results Clinical Trial Heidelberg Pharma AG 2025 Outlook ATAC Technology
BRIEF

published on 03/13/2025 at 07:35, 8 months 23 days ago

Heidelberg Pharma Adjusts Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
PRESS RELEASE

published on 03/13/2025 at 07:30, 8 months 23 days ago

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma and HealthCare Royalty amend royalty financing agreement, providing for USD 20 million payment and extending cash runway into 2027

Amendment Heidelberg Pharma HealthCare Royalty Royalty Financing Cash Runway

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 14 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 19 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 49 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 44 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 49 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:30, 19 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 43 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 48 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 49 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 49 minutes ago

Official List Notice

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 4 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 49 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 4 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 5 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE